Byron Jeffcoat, MD
Sports Medicine · McComb, MSNPI 1750339172
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Smith+Nephew at 25.3% of the total.
Across 96 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$396
- Paratek Pharmaceuticals, Inc.$287
- Pacira Therapeutics, Inc.$175
- Grifols USA, LLC$116
- Amgen$99
- Convatec Inc.$61
- plus $429 from 14 others
What the payments were for
- Food & beverage$1,562100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 31 | $396 |
| Paratek Pharmaceuticals, Inc. | 17 | $287 |
| Pacira Therapeutics, Inc. | 9 | $175 |
| Grifols USA, LLC | 4 | $116 |
| Amgen | 6 | $99 |
| Convatec Inc. | 4 | $61 |
| AbbVie(2 entities) | 4 | $52 |
| Hydrofera LLC | 2 | $50 |
| Vertex | 3 | $49 |
| Bioventus LLC | 3 | $43 |
| Kerecis Limited | 3 | $43 |
| Medela LLC | 1 | $34 |
| Medline Industries LP | 2 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Sandoz | 1 | $22 |
| Aroa Biosurgery Incorporated | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $18 |
| Baudax Bio Inc. | 1 | $16 |
| Sanara Medtech Inc. | 1 | $14 |
| Zimmer Biomet | 1 | $14 |
How this compares
$1,562 in reported general payments places this provider in the 55th percentile of 33 sports medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 104 | $1,063 |
| Celecoxib | 18 | $422 |
| Ibuprofen | 18 | $202 |
| Meloxicam | 90 | $160 |
| Methylprednisolone | 13 | $79 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $68 |
| Gabapentin | 13 | $67 |
| Alendronate Sodium | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in McComb
- James Hurt IiiColumbus$25K
- Hunter HaleyOxford$14K
- Kurre LuberOxford$12K
- Omkar DaveJackson$10K
- Glenn BrienFlowood$8K
- Daniel BoydOxford$6K
- John BerryHattiesburg$5K
- Jason CraftJackson$4K
- Nahum BeardSouthaven$3K
- Jeremy WellsHattiesburg$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.